Litigation Details for CATALYST PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS, INC. (D.N.J. 2023)
✉ Email this page to a colleague
CATALYST PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS, INC. (D.N.J. 2023)
| Docket | ⤷ Start Trial | Date Filed | 2023-03-01 |
| Court | District Court, D. New Jersey | Date Terminated | 2025-01-10 |
| Cause | 35:271 Patent Infringement | Assigned To | Michael E. Farbiarz |
| Jury Demand | None | Referred To | Jose R. Almonte |
| Parties | TEVA PHARMACEUTICALS USA, INC. | ||
| Patents | 10,626,088; 10,793,893; 11,060,128; 11,268,128; 11,274,331; 11,274,332 | ||
| Attorneys | CHRISTINE A. GADDIS | ||
| Firms | Gibbons P.C. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CATALYST PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS, INC.
Details for CATALYST PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS, INC. (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-03-01 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
